Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Technica

    2026-07-24

    Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Technical Application Guide

    What This Product Solves

    During protein extraction from cells and tissues, endogenous proteases and phosphatases can rapidly degrade target proteins, compromising sample integrity and downstream analysis. The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) (SKU K4001) addresses this challenge by providing a defined blend of inhibitors—Aprotinin, Bestatin, E-64, and Leupeptin—that suppress cysteine, serine, acid proteases, and aminopeptidases. Notably, its AEBSF-free formulation minimizes interference with mass spectrometry (MS), supporting workflows where MS artifact avoidance is critical. This product is used to prevent protein degradation in crude extracts, ensuring higher quality and yield in proteomic and biochemical research.

    For further context on optimizing protein extraction for MS workflows, consult the internal article "Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Practical Guide", which discusses compatibility issues and optional EDTA supplementation for metalloproteinase inhibition. Additionally, "Reliable Protein Sample Preparation with Protease Inhibitor Cocktail" provides workflow-driven guidance on maintaining protein integrity and troubleshooting extraction problems.

    Protocol Parameters

    • Assay: General protein extraction
      Value: Use at 1X final concentration (dilute 50X stock 1:50 in extraction buffer)
      Applicability: All cell and tissue lysates requiring protease inhibition
      Rationale: 1X final concentration ensures broad-spectrum inhibition based on manufacturer recommendations for optimal efficacy
      Source Type: Product information
    • Assay: Mass spectrometry–sensitive proteomics
      Value: Omit AEBSF-containing inhibitors; use MS-SAFE exclusively
      Applicability: Workflows requiring MS compatibility
      Rationale: AEBSF can cause peak drift and artifacts in MS; this formulation prevents such interference
      Source Type: Product information
    • Assay: Metalloproteinase inhibition (optional)
      Value: Supplement with EDTA as needed (typical: 1–5 mM; adjust per assay)
      Applicability: Only if metalloproteinase activity is a concern
      Rationale: The cocktail does not inhibit metalloproteinases; EDTA addition is necessary for complete inhibition
      Source Type: Workflow recommendation
    • Assay: Storage
      Value: Store at –20 °C for up to 1 year (avoid repeated freeze-thaw cycles)
      Applicability: All users
      Rationale: Preserves inhibitor potency and prevents degradation
      Source Type: Product information

    Workflow Setup and QC Checklist

    • Buffer Preparation: Thaw the MS-SAFE cocktail on ice. Prepare extraction buffer fresh and ensure it is compatible with DMSO.
    • Inhibitor Addition: Add the cocktail to the extraction buffer immediately before use, ensuring a 1:50 dilution for a 1X working concentration. For workflows requiring metalloproteinase inhibition, add EDTA as appropriate.
    • Temperature Control: Perform all steps on ice or at 4 °C to slow residual enzymatic activity and maximize inhibitor effectiveness.
    • Mixing: Gently invert or pipette to mix; avoid vortexing to prevent foam and protein denaturation.
    • Quality Control: Confirm absence of visible precipitate after dilution. If present, discard and prepare fresh mix.
    • Sample Handling: Process samples promptly after extraction to limit proteolysis; minimize freeze-thaw cycles of both inhibitor and protein extracts.
    • Documentation: Record lot numbers and preparation dates for traceability.

    Common Failure Modes and Fixes

    • Incomplete Protease Inhibition: If proteolysis is observed (e.g., by Western blot), verify correct dilution and addition of the cocktail. Ensure EDTA is included if metalloproteinase activity is suspected.
    • MS Interference: If mass spectrometry peak drift occurs, confirm that no AEBSF or other interfering agents were added. Use the AEBSF-free MS-SAFE formulation exclusively.
    • Precipitation or Cloudiness: If the diluted cocktail forms a precipitate, discard and prepare fresh. Warm gently to room temperature if needed, but do not exceed 25 °C.
    • DMSO Incompatibility: Some sensitive assays or buffers may be incompatible with DMSO. In such cases, test buffer stability with a small aliquot before full-scale extraction.

    Scope and Limitations

    • This cocktail is designed for broad-spectrum protease inhibition, excluding metalloproteinases (unless supplemented with EDTA). It is not suitable when AEBSF-sensitive serine protease inhibition is essential.
    • DMSO as a solvent may not be compatible with every buffer system; pilot testing is recommended for novel protocols.
    • For workflows requiring inhibition of additional enzyme classes (e.g., phosphatases beyond the included spectrum), supplementary inhibitors may be required.
    • Not intended for clinical or in vivo use.
    • Proper storage and handling are essential to maintain efficacy; avoid repeated freeze-thaw cycles and prolonged exposure to room temperature.

    Conclusion

    The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) offers a targeted solution for protein degradation prevention during extraction, especially in workflows where mass spectrometry compatibility is required. Its AEBSF-free formulation, broad specificity (including cysteine protease inhibition), and convenience as a ready-to-use concentrate make it a preferred option for researchers prioritizing sample integrity and MS analysis. For reliable results, follow recommended dilution, consider buffer compatibility, and supplement with EDTA when metalloproteinase inhibition is necessary. For detailed procedural guidance and troubleshooting, additional resources are available from APExBIO and in referenced internal articles above.